IRCT20210519051345N18尚未招募未知
Bioequivalence study of Warfarin 5 mg tablet compared with innovator product
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney disease,
- •Alcohol and drug addiction,
- •History of drug allergy
研究者
相似试验
招募中
4 期
Outcomes of Warfarin and Rivaroxaban (Xalerban) consumption in patients with Atrial fibrillatioIRCT20170530034232N2Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences330
尚未招募
不适用
Comparison of Efficacy and Safety between Warfarin, Rivaroxaban and Edoxaban in patients with acute pulmonary embolism in showa universityJPRN-UMIN000020069Division of Cardiology, Department of Medicine,Showa university100
招募中
2 期
Effect of warfarin and rivaroxaban in coronary endartherectomyIRCT20181124041746N1Kermanshah University of Medical Sciences120
撤回
4 期
A Prospective Study on Warfarin Management Post Heart Valve Replacement or Heart Valve Repair SurgeryPost Mechanical Heart Valve SurgeryWarfarin Management in post mechanical heart valve surgery patients.Cardiovascular - Other cardiovascular diseasesSurgery - Other surgeryACTRN12613000818730Flinders Medical Centre140
已完成
3 期
A clinical trial studying if the 10mg initiation dose achieves anticoagulation faster than the 5mg initiation dose in the treatment of acute deep vein thrombosis, while maintaining safety and efficacy.CTRI/2016/10/007346Fluid Research Grant Christian Medical College Vellore60